OCULAR THERAPEUTIX,INC. (NASDAQ:OCUL) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Submission of Matters to a Vote of Security Holders.
Ocular Therapeutix held its Annual Meeting of Stockholders on June14, 2018. The following is a summary of the matters voted on at that meeting.
(a) |
Ocular Therapeutix’s stockholders elected Antony Mattessich, W. James O’Shea and Charles Warden as ClassI directors to serve until the 2021 Annual Meeting of Stockholders, each such director to hold office until his successor has been duly elected and qualified. The results of the stockholders’ vote with respect to the election of such ClassI directors were as follows: |
Name |
VotesFor |
Votes Withheld |
Broker Non-Votes |
Antony Mattessich |
15,588,755 |
3,217,038 |
14,553,989 |
W. James O’Shea |
14,447,012 |
4,358,781 |
14,553,989 |
Charles Warden |
14,949,006 |
3,856,787 |
14,553,989 |
(b) |
Ocular Therapeutix’s stockholders ratified the selection of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December31, 2018. The result of the stockholders’ vote with respect to such ratification were as follows: |
For |
Against |
Abstain |
BrokerNon-Votes |
32,785,789 |
286,003 |
287,990 |
|